lupin-tiotropium capsule
lupin pharma canada limited - tiotropium (tiotropium bromide monohydrate) - capsule - 18mcg - tiotropium (tiotropium bromide monohydrate) 18mcg
tiotropium propharma group, 18 microgram, inhalation powder, hard capsule
propharma group netherlands b.v. - anhydrous tiotropium bromide - inhalation powder, hard capsule - 18 microgram(s) - tiotropium bromide
stiolto respimat- tiotropium bromide and olodaterol spray, metered
boehringer ingelheim pharmaceuticals inc. - tiotropium bromide monohydrate (unii: l64sxo195n) (tiotropium - unii:0eb439235f), olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - tiotropium 3.124 ug - stiolto respimat is a combination of tiotropium and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. important limitations of use - stiolto respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2)]. - stiolto respimat is not indicated to treat asthma. the safety and effectiveness of stiolto respimat in asthma have not been established. use of a laba, including stiolto respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1)] . stiolto respimat is not indicated for the treatment of asthma. stiolto respimat is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product [see warnings and precautions (5.4)] . in clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, inc
tiotropium demo 18mcg inhalation powder in hard capsules
demo s.a. (0000003568) 21st km national road athens-lamia, krioneri, attiki, 14568 - tiotropium bromide anhydrous - inhalation powder in hard capsules - 18mcg - tiotropium bromide anhydrous (0136310935) 21.700000000000ug
tiotropium bmodesto 10 microgram/dosis inhalatiepoeder in harde capsules
bmodesto b.v. minervaweg 2 8239 dl lelystad - tiotropiumbromide 0-water samenstelling overeenkomend met ; tiotropium - inhalatiepoeder in harde capsule - hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 1-water - tiotropium bromide
tiotropium bmodesto 10 microgram/dosis inhalatiepoeder in harde capsules
bmodesto b.v. minervaweg 2 8239 dl lelystad - tiotropiumbromide 0-water samenstelling overeenkomend met ; tiotropium - inhalatiepoeder in harde capsule - hypromellose (e 464) ; lactose 1-water - tiotropium bromide
tiotropium bmodesto 10 microgram/dosis inhalatiepoeder in harde capsules
bmodesto b.v. minervaweg 2 8239 dl lelystad - tiotropiumbromide 0-water samenstelling overeenkomend met ; tiotropium - inhalatiepoeder in harde capsule - hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; lactose 1-water - tiotropium bromide
spiriva respimat tiotropium 2.5 micrograms/actuation solution for inhalation cartridge
boehringer ingelheim pty ltd - tiotropium bromide monohydrate, quantity: 3.1235 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; hydrochloric acid; disodium edetate; benzalkonium chloride - copd: spiriva respimat is indicated for the long term maintenance treatment of bronchospasm and dyspnoea associated with chronic obstructive pulmonary disease (copd). spiriva respimat is indicated for the prevention of copd exacerbations.,asthma: spiriva respimat is indicated as add-on maintenance bronchodilator treatment in patients aged 6 years and older with moderate to severe asthma.
tiotropium viatris 18 µg inhal. pwdr. (hard caps.)
viatris gx bv-srl - tiotropium bromide 21,67 µg - eq. tiotropium 18 µg - inhalation powder, hard capsule - 18 µg - tiotropium bromide 21.67 µg - tiotropium bromide
tiotropium demo 18 µg inhal. pwdr. (hard caps.)
demo pharmaceutical industry s.a. - tiotropium bromide 21,7 µg - eq. tiotropium 18 µg - inhalation powder, hard capsule - 18 µg - tiotropium bromide 21.7 µg - tiotropium bromide